NGNE

NEUROGENE INC

NGNE·64135M105·US·Common Stock·Healthcare - Biotechnology-13D/G

NGNE (NEUROGENE INC) is held by 66 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($27.5M), BlackRock, Inc. ($20.3M), BAKER BROS. ADVISORS LP ($20M). Net institutional sentiment: Bullish.

66
Holders
Avg rating(15 Elite)
$182.4M
Total Value
68% (73)
Fund Consensus
42 buying - 20 selling
NGNESmart Money Verdict
View all
Held by 66 funds
15 elite
Who's Trading
InsiderCMCvijic Christine MikailSell $144KMay 6, 2026
InsiderCMCvijic Christine MikailSell $156KMay 6, 2026
InsiderMRMcMinn RachelSell $74KMar 26, 2026
InsiderCMCvijic Christine MikailSell $55KMar 26, 2026
InsiderJJJordan JulieSell $18KMar 26, 2026
InsiderCMCvijic Christine MikailSell $49KMar 13, 2026
InsiderCMCvijic Christine MikailSell $30KMar 13, 2026
InsiderCMCvijic Christine MikailSell $6KMar 13, 2026
ActivistRERedmile Group, LLC9.9%Feb 17, 2026
ActivistTETrails Edge Capital Partners, LP5.1%Dec 15, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.4M$27.5M0.3%-6.38%
0
Increased
1M(+6.3%)$20.3M0.0%+78.01%
30
Unchanged
991,691$20M0.1%+130.34%
0
Increased
718,389(+18.0%)$14.5M0.0%+115.80%
33
Unchanged
681,337$13.7M0.0%+154.30%
0
Decreased
527,685(-1.0%)$10.6M0.0%+83.88%
0
New
514,727$10.4M0.0%+80.22%
38
Increased
387,031(+6.3%)$7.8M0.0%+79.30%
29
Increased
382,647(+193.6%)$7.7M0.0%+79.65%
44
Increased
313,005(+1.7%)$6.3M0.0%+20.59%
28
Decreased
285,239(-23.1%)$5.8M0.0%+48.05%
0
Increased
279,003(+11.7%)$5.6M0.0%+11.97%
30
Increased
204,809(+187.2%)$4.1M0.0%+101.51%
43
Increased
185,679(+20.5%)$3.7M0.0%+81.73%
32
Increased
168,218(+2.8%)$3.4M0.0%+115.18%
27
Decreased
107,714(-33.5%)$2.2M0.0%+92.19%
0
Increased
106,255(+24.2%)$2.1M0.0%+8.63%
32
Increased
97,621(+14.1%)$2M0.0%+7.35%
29
Unchanged
83,835$1.7M0.0%-1.25%
0
New
69,712$1.4M0.0%+80.22%
35

Showing 1-20 of 73

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used